Skip to main content

Table 4 Risk factors in PCOS patients with NAFLD and without NAFLD

From: Hepatic steatosis in women with polycystic ovary syndrome

 

Non-NAFLD N(%)

NAFLD N(%)

P

Central obesity

47 (35.3%)

62 (88.6%)

< 0.001

Increased blood pressure

8 (17.4%)

19 (52.8%)

0.001

Hypertriglyceridemia

13 (9.1%)

27 (37.5%)

< 0.001

Hyperlipidemia

47 (32.9%)

42 (58.3%)

< 0.001

Abnormal blood glucose

24 (16.9%)

30 (41.7%)

< 0.001

HOMA-IR ≥ 3.54

5 (3.6%)

56 (81.2%)

< 0.001

Metabolic syndrome

1 (0.7%)

35 (47.9%)

< 0.001

Abnormal liver enzymes

5 (3.5%)

23 (31.5%)

< 0.001

ALT ≥ 18.2

42 (29.2%)

54 (74.0%)

< 0.001

FAI > 8

36 (28.6%)

42 (68.9%)

< 0.001

Hirsutism

42 (30.0%)

28 (38.9%)

0.964

Acne

68 (48.2%)

31 (43.1%)

0.674

PCOM

114 (88.4%)

60 (95.2%)

0.124

  1. The ‘N (%)’ in each cell represented ‘the number of patients with this risk factor in this age group (the percentage of patients with this risk factor in this age group). Patients were excluded if the factor to be analyzed was missing